The guanylin family of cGMP-regulating peptides has three subclasses of pep
tides containing either three intramolecular disulfides found in bacterial
heat-stable enterotoxins (ST)I or two disulfides observed in guanylin and u
roguanylin, or a single disulfide exemplified by lymphoganylin. These small
, heat-stable peptides bind to and activate cell-surface receptors that hav
e intrinsic guanylate cyclase (GC) activity. Two receptor GC signaling mole
cules have been identified that are highly expressed in the intestine (GC-C
) and/or the kidney (OK-GC) and are selectively activated by the guanylin p
eptides. Stimulation of cGMP production in renal target cells by guanylin p
eptides in vivo or ex vivo elicits a long-lived diuresis, natriuresis, and
kaliuresis. Activation of GC-C receptors in target cells of intestinal muco
sa markedly stimulates the transepithelial secretion of Cl- and HCO,, causi
ng enhanced secretion of fluid and electrolytes into the intestinal lumen.
Bacterial ST peptides act as mimics of guanylin and uroguanylin in the inte
stine, which provide a cellular mechanism underlying the diarrhea caused by
ST-secreting strains of Escherichia coli. Uroguanylin and guanylin may par
ticipate in a novel endocrine axis linking the digestive system and kidney
as a physiological mechanism that influences Na+ homeostasis. Guanylin, uro
guanylin, and/or lymphoguanylin may also serve within intrarenal signaling
pathways controlling cGMP production in renal target cells. Thus we propose
that guanylin regulatory peptides participate in a complex multifactorial
biological process that evolved to regulate the urinary excretion of NaCl w
hen dietary salt levels exceed the body's physiological requirements. This
highly integrated and redundant mechanism allows the organism to maintain s
odium balance by eliminating excess NaCl in the urine. Uroguanylin, in part
icular, may be a prototypical "intestinal natriuretic hormone.".